Stoke Therapeutics's three largest insider shareholders as of May 30, 2026 are Trust Skorpios (TenPercentOwner, 3.91Mn shares), Adrian R. Krainer (Director, 283.30K shares), Edward M. Md Kaye (Ceo, 110.87K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Arthur A Levin | - | 4,237 | 0 | 17 Mar, 2026 |
| Stephen J Tulipano | Cfo | 20,746 | 0 | 19 Mar, 2024 |
| Edward M. Md Kaye | Ceo | 110,874 | 0 | 17 Mar, 2026 |
| Arthur Tzianabos | Interim Executive Chair | 31,339 | 0 | 12 Mar, 2026 |
| Jason Hoitt | Chief Patient Officer | 10,276 | 0 | 19 Mar, 2026 |
| Thomas Leggett | Chief Financial Officer | 10,172 | 0 | 19 Mar, 2026 |
| Adrian R. Krainer | - | 283,302 | 0 | 12 Mar, 2026 |
| Barry Ticho | Chief Medical Officer | 38,864 | 0 | 03 Apr, 2026 |
| Trust Skorpios | - | 0 | 3,906,181 | 06 Jun, 2025 |
| Jonathan Allan | General Counsel Corp Sec | 19,543 | 0 | 24 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Apr, 2026 | Clare Kahn | Stock Option (Right to Buy) | A | 30,782 | $0.00 | 30,782 | D | A |
| 01 Apr, 2026 | Barry Ticho | Common Stock | D | 1,838 | $32.66 | 38,864 | D | S |
| 01 Apr, 2026 | Barry Ticho | Common Stock | D | 1,838 | $32.66 | 38,864 | D | S |
| 01 Apr, 2026 | Barry Ticho | Common Stock | D | 1,838 | $32.66 | 38,864 | D | S |
| 20 Mar, 2026 | Jonathan Allan | Common Stock | D | 8,692 | $33.64 | 20,144 | D | S |
| 20 Mar, 2026 | Jonathan Allan | Common Stock | D | 601 | $34.41 | 19,543 | D | S |
| 17 Mar, 2026 | Barry Ticho | Common Stock | D | 3,577 | $32.74 | 50,071 | D | S |
| 17 Mar, 2026 | Barry Ticho | Common Stock | D | 3,577 | $32.74 | 50,071 | D | S |
| 17 Mar, 2026 | Barry Ticho | Common Stock | D | 3,577 | $32.74 | 50,071 | D | S |
| 17 Mar, 2026 | Jason Hoitt | Common Stock | D | 1,033 | $32.74 | 12,955 | D | S |
| 17 Mar, 2026 | Jonathan Allan | Common Stock | D | 2,476 | $32.74 | 35,255 | D | S |
| 17 Mar, 2026 | Thomas Leggett | Common Stock | D | 1,274 | $32.74 | 13,476 | D | S |
| 17 Mar, 2026 | Jason Hoitt | Common Stock | D | 748 | $33.38 | 12,207 | D | S |
| 17 Mar, 2026 | Jonathan Allan | Common Stock | D | 1,791 | $33.38 | 33,464 | D | S |
| 17 Mar, 2026 | Barry Ticho | Common Stock | D | 2,587 | $33.38 | 47,484 | D | S |
| 17 Mar, 2026 | Barry Ticho | Common Stock | D | 2,587 | $33.38 | 47,484 | D | S |
| 17 Mar, 2026 | Barry Ticho | Common Stock | D | 2,587 | $33.38 | 47,484 | D | S |
| 17 Mar, 2026 | Thomas Leggett | Common Stock | D | 922 | $33.38 | 12,554 | D | S |
| 18 Mar, 2026 | Jonathan Allan | Common Stock | D | 4,222 | $31.28 | 29,242 | D | S |
| 18 Mar, 2026 | Barry Ticho | Common Stock | D | 6,100 | $31.28 | 41,384 | D | S |